Apolipoprotein-mediated removal of cellular cholesterol and phospholipids.

[1]  C. Fielding,et al.  Unique epitope of apolipoprotein A-I expressed in pre-beta-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol. , 1994, Biochemistry.

[2]  N. Savion,et al.  Role of apolipoproteins A-I, A-II and C-I in cholesterol efflux from endothelial and smooth muscle cells. , 1993, European heart journal.

[3]  M. Gottesman,et al.  Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.

[4]  J. Swaney.  Selective proteolytic digestion as a method for the modification of human HDL3 structure. , 1983, Journal of lipid research.

[5]  D. Reichl.  Lipoproteins of human peripheral lymph. , 1990, European heart journal.

[6]  K. Åkerman,et al.  High-density lipoproteins induce a rapid and transient release of Ca2+ in cultured fibroblasts. , 1991, The Biochemical journal.

[7]  L. Avioli,et al.  Tangier Disease: Combined Clinical Staff Conference at the National Institutes of Health , 1961 .

[8]  Y. Lange.  Tracking cell cholesterol with cholesterol oxidase. , 1992, Journal of lipid research.

[9]  J. Taylor,et al.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. , 1995, The Journal of clinical investigation.

[10]  T. Forte,et al.  Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. , 1992, Biochimica et biophysica acta.

[11]  Y. Lange,et al.  Disposition of intracellular cholesterol in human fibroblasts. , 1991, Journal of lipid research.

[12]  T. Kita,et al.  High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Howell,et al.  Characterization and purification of proteins which bind high-density lipoprotein. A putative cell-surface receptor. , 1991, The Biochemical journal.

[14]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[15]  J. Oram,et al.  Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. Evidence for reversible binding at the cell surface without internalization. , 1987, The Journal of biological chemistry.

[16]  R. Krauss,et al.  Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.

[17]  Helen H. Hobbs,et al.  Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.

[18]  J. Breslow,et al.  Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Albers,et al.  Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues. , 1986, The Journal of biological chemistry.

[20]  W. Willett,et al.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.

[21]  É. Kurucz,et al.  Lipid composition of HDL subfractions in dog plasma and lymph. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[22]  P. Visser,et al.  Structural relation between HDL-binding proteins in porcine liver. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[23]  W. J. Johnson,et al.  Efflux of phospholipid from fibroblasts with normal and elevated levels of cholesterol. , 1991, Biochimica et biophysica acta.

[24]  A. von Eckardstein,et al.  Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[25]  G. Rothblat,et al.  Influence of apolipoproteins AI, AII, and Cs on the metabolism of membrane and lysosomal cholesterol in macrophages. , 1991, The Journal of biological chemistry.

[26]  D. Sviridov,et al.  Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles. , 1996, Biochemistry.

[27]  E. Dusserre,et al.  High-density lipoprotein 3 stimulates phosphatidylcholine breakdown and sterol translocation in rat aortic smooth muscle cells by a phospholipase C/protein kinase C-dependent process. , 1994, Biochemical medicine and metabolic biology.

[28]  S. Yokoyama,et al.  Behavior of human apolipoprotein E in aqueous solutions and at interfaces. , 1985, The Journal of biological chemistry.

[29]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[30]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[31]  P. Barter,et al.  Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools. , 1995, Biochimica et biophysica acta.

[32]  G. Francis,et al.  Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Hokland,et al.  Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading of cells. , 1992, The Journal of biological chemistry.

[34]  J. Oram,et al.  Identification and characterization of a high density lipoprotein-binding protein in cell membranes by ligand blotting. , 1987, The Journal of biological chemistry.

[35]  J. Slotte,et al.  Cyclic AMP stimulates efflux of intracellular sterol from cholesterol-loaded cells. , 1993, The Journal of biological chemistry.

[36]  H. Hoff,et al.  Lipoproteins containing apolipoprotein A-I extracted from human aortas. , 1982, Biochimica et biophysica acta.

[37]  L. Zech,et al.  Cholesterol kinetics in subjects with bile fistula. Positive relationship between size of the bile acid precursor pool and bile acid synthetic rate. , 1993, The Journal of clinical investigation.

[38]  S. Yokoyama,et al.  Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol. , 1992, The Journal of biological chemistry.

[39]  B. Knowles,et al.  Isolation and characterization of lipoproteins produced by human hepatoma-derived cell lines other than HepG2. , 1989, Journal of lipid research.

[40]  S. Yokoyama,et al.  Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. , 1991, The Journal of biological chemistry.

[41]  J. Kane,et al.  Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-beta high-density lipoprotein particles. , 1993, Biochemistry.

[42]  J. Albers,et al.  Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. , 1984, The Journal of biological chemistry.

[43]  W. J. Johnson,et al.  The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein. , 1994, The Journal of biological chemistry.

[44]  T. Forte,et al.  Heterogeneity of nascent high density lipoproteins secreted by the hepatoma-derived cell line, Hep G2. , 1988, Journal of lipid research.

[45]  A. Rigotti,et al.  Sterol Carrier Protein-2 Is Involved in Cholesterol Transfer from the Endoplasmic Reticulum to the Plasma Membrane in Human Fibroblasts (*) , 1995, The Journal of Biological Chemistry.

[46]  S. Yokoyama,et al.  Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol. , 1996, Biochemistry.

[47]  A. Mendez,et al.  Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. , 1991, The Journal of biological chemistry.

[48]  W. J. Johnson,et al.  The bidirectional flux of cholesterol between cells and lipoproteins. Effects of phospholipid depletion of high density lipoprotein. , 1986, The Journal of biological chemistry.

[49]  N. Fidge,et al.  Affinity purification of the hepatic high-density lipoprotein receptor identifies two acidic glycoproteins and enables further characterization of their binding properties. , 1992, The Biochemical journal.

[50]  L. Rudel,et al.  Nascent lipoproteins from recirculating and nonrecirculating liver perfusions and from the hepatic Golgi apparatus of African green monkeys. , 1987, Journal of lipid research.

[51]  S. Skarlatos,et al.  Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux. , 1994, The Journal of biological chemistry.

[52]  K. Williams,et al.  The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[53]  W. J. Johnson,et al.  Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. , 1992, Journal of lipid research.

[54]  G. Anantharamaiah,et al.  The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. , 1992, Journal of lipid research.

[55]  D. Sviridov,et al.  Efflux of intracellular versus plasma membrane cholesterol in HepG2 cells: different availability and regulation by apolipoprotein A-I. , 1995, Journal of lipid research.

[56]  G. Schmitz,et al.  High-density lipoprotein and low-density lipoprotein-mediated signal transduction in cultured human skin fibroblasts. , 1995, Cellular signalling.

[57]  S. Horiuchi,et al.  Cross‐linking of apolipoproteins is involved in a loss of the ligand activity of high density lipoprotein upon Cu2+‐mediated oxidation , 1992, FEBS letters.

[58]  T. Forte,et al.  Structural relationships between nascent apoA-I-containing particles that are extracellularly assembled in cell culture. , 1996, Journal of lipid research.

[59]  W. J. Johnson,et al.  The influence of cellular and lipoprotein cholesterol contents on the flux of cholesterol between fibroblasts and high density lipoprotein. , 1988, The Journal of biological chemistry.

[60]  J. Oram,et al.  Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. , 1983, The Journal of clinical investigation.

[61]  B. G. Brown,et al.  Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. , 1991, Journal of lipid research.

[62]  I. Goldberg,et al.  Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. , 1993, The Journal of clinical investigation.

[63]  G. Schmitz,et al.  Activation of phosphatidylinositol-specific phospholipase C in response to HDL3 and LDL is markedly reduced in cultured fibroblasts from Tangier patients. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[64]  E. Rubin,et al.  Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice. , 1994, Journal of lipid research.

[65]  S. Horiuchi,et al.  Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[66]  J. Slotte,et al.  High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[67]  T. Mazzone,et al.  Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3. , 1994, Journal of lipid research.

[68]  A. Mendez.  Monensin and Brefeldin A Inhibit High Density Lipoprotein- mediated Cholesterol Efflux from Cholesterol-enriched Cells , 1995, The Journal of Biological Chemistry.

[69]  H. Brewer,et al.  Human proapoA-ITangier: isolation of proapoA-ITangier and amino acid sequence of the propeptide. , 1983, Biochemical and biophysical research communications.

[70]  G. Assmann,et al.  HDL3 stimulates multiple signaling pathways in human skin fibroblasts. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[71]  W. J. Johnson,et al.  The Effect of High Density Lipoprotein Phospholipid Acyl Chain Composition on the Efflux of Cellular Free Cholesterol (*) , 1995, The Journal of Biological Chemistry.

[72]  A. Mendez,et al.  Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. , 1994, The Journal of clinical investigation.

[73]  Y. Lange.  Cholesterol movement from plasma membrane to rough endoplasmic reticulum. Inhibition by progesterone. , 1994, The Journal of biological chemistry.

[74]  P. Denéfle,et al.  Protection Against Atherogenesis in Mice Mediated by Human Apolipoprotein A-IV , 1996, Science.

[75]  C. Ashall,et al.  High-density-lipoprotein (HDL) subfractions in interstitial fluid from human aortic intima and atherosclerotic lesions , 1984 .

[76]  L. Dory,et al.  Regulation of apolipoprotein E secretion by high density lipoprotein 3 in mouse macrophages. , 1991, Journal of lipid research.

[77]  S. Yokoyama,et al.  Involvement of a cellular surface factor(s) in lipid-free apolipoprotein-mediated cellular cholesterol efflux. , 1995, Biochimica et biophysica acta.

[78]  S. Yokoyama,et al.  Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells. , 1993, Biochemistry.

[79]  M. Phillips,et al.  Role of apolipoproteins in cellular cholesterol efflux. , 1986, Biochimica et biophysica acta.

[80]  J. S. Owen,et al.  Human high density lipoproteins stimulate endothelin-1 release by cultured human renal proximal tubular cells. , 1994, Kidney international.

[81]  D. Steinberg,et al.  Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. , 1985, The Journal of biological chemistry.

[82]  M. Lagarde,et al.  Leukotriene B4 levels from stimulated neutrophils from healthy and allergic subjects: effect of platelets and exogenous arachidonic acid , 1991, European journal of clinical investigation.

[83]  S. Yokoyama,et al.  Independent Regulation of Cholesterol Incorporation into Free Apolipoprotein-mediated Cellular Lipid Efflux in Rat Vascular Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[84]  C. Fielding,et al.  Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.

[85]  W. Blackburn,et al.  Apolipoprotein A-I decreases neutrophil degranulation and superoxide production. , 1991, Journal of lipid research.

[86]  G. Francis,et al.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.

[87]  G. Rothblat,et al.  Cellular cholesterol efflux. Role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs. , 1992, The Journal of biological chemistry.

[88]  J. Oram,et al.  Regulation of High Density Lipoprotein Binding Activity of Aortic Endothelial Cells by Treatment with Acetylated Low Density Lipoprotein , 1985, Arteriosclerosis.

[89]  Y. Lange,et al.  Cholesterol-rich intracellular membranes: a precursor to the plasma membrane. , 1985, The Journal of biological chemistry.

[90]  R. G. Anderson,et al.  Caveolae: where incoming and outgoing messengers meet. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[91]  T. Hughes,et al.  A novel cell line (Caco-2) for the study of intestinal lipoprotein synthesis. , 1987, The Journal of biological chemistry.

[92]  J. Dietschy,et al.  Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. , 1993, Journal of lipid research.

[93]  W. J. Johnson,et al.  Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. , 1992, Journal of lipid research.

[94]  A. von Eckardstein,et al.  A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[95]  M. Savolainen,et al.  Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. , 1994, Atherosclerosis.

[96]  T. Forte,et al.  Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. , 1993, Journal of lipid research.

[97]  A. von Eckardstein,et al.  Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[98]  S. Kunitake,et al.  Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. , 1992, Journal of lipid research.

[99]  J. Slotte,et al.  Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface. , 1987, The Journal of biological chemistry.

[100]  L. Rudel,et al.  High density lipoprotein accumulation in perfusates of isolated livers of African green monkeys. Effects of saturated versus polyunsaturated dietary fat. , 1988, Journal of lipid research.

[101]  M. Katsuki,et al.  Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. , 1995, The Journal of clinical investigation.

[102]  V. Fadok,et al.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. , 1992, Journal of immunology.

[103]  C. Fielding,et al.  Plasma membrane caveolae mediate the efflux of cellular free cholesterol. , 1995, Biochemistry.

[104]  G. Bloom,et al.  Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps , 1995, The Journal of cell biology.

[105]  A. Tall.  Plasma cholesteryl ester transfer protein. , 1993, Journal of lipid research.

[106]  M. Jauhiainen,et al.  Pig plasma phospholipid transfer protein facilitates HDL interconversion. , 1995, Journal of lipid research.

[107]  R. Gregg,et al.  In vivo metabolism of proapolipoprotein A-I in Tangier disease. , 1987, The Journal of clinical investigation.

[108]  G. Vassaux,et al.  Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation. , 1990, Biochemical and biophysical research communications.

[109]  T. Mazzone,et al.  Growth-related modulation of human skin fibroblast cholesterol distribution and metabolism. , 1990, Biochimica et biophysica acta.

[110]  J. Oram,et al.  Nonenzymatic Glycosylation of HDL and Impaired HDL-Receptor–Mediated Cholesterol Efflux , 1991, Diabetes.

[111]  B. Asztalos,et al.  Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[112]  S. Yokoyama,et al.  Effect of lipid particle size on association of apolipoproteins with lipid. , 1983, The Journal of biological chemistry.

[113]  L. Liscum,et al.  Intracellular Cholesterol Transport and Compartmentation (*) , 1995, The Journal of Biological Chemistry.

[114]  J. Oram,et al.  Nonenzymatic Glycosylation of HDL Resulting in Inhibition of High-Affinity Binding to Cultured Human Fibroblasts , 1990, Diabetes.

[115]  Y. Marcel,et al.  The amphipathic alpha-helical repeats of apolipoprotein A-I are responsible for binding of high density lipoproteins to HepG2 cells. , 1991, The Journal of biological chemistry.

[116]  W. J. Johnson,et al.  Effects of Acceptor Particle Size on the Efflux of Cellular Free Cholesterol (*) , 1995, The Journal of Biological Chemistry.

[117]  D. Gordon,et al.  High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.

[118]  S. Kihara,et al.  Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[119]  T. Forte,et al.  Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. , 1995, Journal of lipid research.

[120]  H. Brewer,et al.  Tangier disease. The complete mRNA sequence encoding for preproapo-A-I. , 1985, The Journal of biological chemistry.

[121]  S. Yokoyama,et al.  Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. , 1995, Biochemistry.

[122]  G. Assmann,et al.  The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects. , 1994, Biochemical and biophysical research communications.

[123]  L. Liscum,et al.  Intracellular cholesterol transport. , 1992, Journal of lipid research.

[124]  D. Black,et al.  Intestinal Apolipoprotein Synthesis in the Newborn Piglet , 1991, Pediatric Research.

[125]  T. Voyno-Yasenetskaya,et al.  Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[126]  R. Havel,et al.  Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[127]  G. Franceschini,et al.  AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission. , 1985, American journal of human genetics.

[128]  D. Fredrickson.  THE INHERITANCE OF HIGH DENSITY LIPOPROTEIN DEFICIENCY (TANGIER DISEASE). , 1964, The Journal of clinical investigation.

[129]  Hao Li,et al.  Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[130]  E. Rubin,et al.  Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. , 1994, The Journal of clinical investigation.

[131]  A. Mendez,et al.  Cellular localization and characterization of proteins that bind high density lipoprotein. , 1992, Journal of lipid research.

[132]  A. Mendez,et al.  Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus. , 1996, Journal of lipid research.

[133]  W. J. Johnson,et al.  Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. , 1995, Biochemistry.

[134]  S. Yokoyama,et al.  Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: proposal of a putative model for the pre-beta high-density lipoprotein pathway. , 1992, Biochemistry.

[135]  Y. Chao,et al.  Nascent high density lipoproteins from liver perfusates of orotic acid-fed rats. , 1986, Journal of lipid research.

[136]  I. Tabas,et al.  Lipoproteins activate acyl-coenzyme A:cholesterol acyltransferase in macrophages only after cellular cholesterol pools are expanded to a critical threshold level. , 1991, The Journal of biological chemistry.

[137]  N. Miller,et al.  Lipoproteins of human peripheral lymph. Apolipoprotein AI‐containing lipoprotein with alpha‐2 electrophoretic mobility , 1991, European journal of clinical investigation.

[138]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[139]  R. Lees,et al.  Homozygous Tangier disease and cardiovascular disease. , 1994, Atherosclerosis.

[140]  E. Levin,et al.  High density lipoproteins stimulate the production and secretion of endothelin-1 from cultured bovine aortic endothelial cells. , 1994, The Journal of clinical investigation.

[141]  A. Mendez,et al.  Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux. , 1993, The Journal of clinical investigation.

[142]  Y. Q. Wu,et al.  High density lipoproteins stimulate molecular weight 80K protein phosphorylation in human trophoblast cells: evidence for a protein kinase-C-dependent pathway in human placental lactogen release. , 1992, Endocrinology.

[143]  J. Qiao,et al.  Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. , 1993, Science.

[144]  R. Mahley,et al.  Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. , 1983, The Journal of biological chemistry.

[145]  E. Rubin,et al.  Protein composition determines the anti-atherogenic properties of HDL in transgenic mice , 1993, Nature.

[146]  C. Fielding,et al.  Quantitation of pre beta-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid. , 1993, Biochemistry.

[147]  D M Foster,et al.  Protein transfer between A-I-containing lipoprotein subpopulations: evidence of non-transferable A-I in particles with A-II. , 1992, Biochimica et biophysica acta.

[148]  J. Kane,et al.  Pre-beta high density lipoprotein. Unique disposition of apolipoprotein A-I increases susceptibility to proteolysis. , 1990, Arteriosclerosis.

[149]  J. Witztum,et al.  Plasma Apolipoproteins AI, AII, B, CI, and E Are Glucosylated in Hyperglycemic Diabetic Subjects , 1985, Diabetes.

[150]  C. Fielding,et al.  Regulation of the concentration of pre beta high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity. , 1992, Biochemistry.

[151]  G. Assmann,et al.  Regulation of high density lipoprotein receptors in cultured macrophages: role of acyl‐CoA:cholesterol acyltransferase. , 1985, The EMBO journal.

[152]  S. Yokoyama,et al.  Regulation of Cellular Cholesterol Efflux by Lecithin:Cholesterol Acyltransferase Reaction through Nonspecific Lipid Exchange (*) , 1996, The Journal of Biological Chemistry.

[153]  W. J. Johnson,et al.  Cholesterol transport between cells and high-density lipoproteins. , 1991, Biochimica et biophysica acta.

[154]  C. Sloop,et al.  Comparison of apo A-I-containing subpopulations of dog plasma and prenodal peripheral lymph: evidence for alteration in subpopulations in the interstitial space. , 1993, Biochimica et biophysica acta.

[155]  J. Oram,et al.  High density lipoprotein stimulates sterol translocation between intracellular and plasma membrane pools in human monocyte-derived macrophages. , 1989, Journal of lipid research.

[156]  E. Schaefer.  Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency. , 1984, Arteriosclerosis.